Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Protagonist Therapeutics Inc (PTGX)

11.98 -0.02 (-0.17%)

6/26/2017  2:50pm

Open:

12.07

Pre. Close:

12.00

High:

12.10

Low:

11.15

Volume:

76,492

Market Cap:

201.93M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

12.14 - 12.14

12.14 - 12.09

Low:

10.73 - 10.73

10.73 - 11.81

Close:

11.37 - 11.37

11.37 - 12

Technical analysis  (as of: 2017-06-26 2:32:21 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 17.34     One year: 20.26

Support:

Support1: 10.62    Support2: 8.00

Resistance:

Resistance1: 14.85    Resistance2: 17.34

Pivot:

11.20

Moving Averages:

MA(5): 11.96     MA(20): 10.93

MA(100): 12.35     MA(250):

MACD:

MACD(12,26): 0.39     Signal(12,26,9): 0.25

%K %D:

%K(14,3): 82.05     %D(3): 70.17

RSI:

RSI(14): 58.98

52-Week:

High: 26.36  Low: 8.00  Change(%): 1.6

Average Vol(K):

3-Month: 110  10-Days 110

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
PTGX has closed below upper band by 20.6%. Bollinger Bands are 22.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 08 Jun 2017 12:00:00 GMT
Protagonist Therapeutics Appoints Five Prime Therapeutics CEO, Lewis T. "Rusty ...

Tue, 30 May 2017 10:52:30 GMT
Protagonist Therapeutics Enters into Worldwide Agreement with Janssen to Co ...

Thu, 25 May 2017 12:00:00 GMT
Protagonist Therapeutics Initiates Phase 1 Study with Novel Hepcidin Mimetic ...

Wed, 10 May 2017 20:07:42 GMT
Protagonist Therapeutics Reports First Quarter 2017 Financial Results

Mon, 14 Nov 2016 21:26:11 GMT
Protagonist Therapeutics Reports Third Quarter 2016 Financial Results and ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

16.86

Shares Float (M)

7.03

% Held by Insiders

% Held by Institutions

Shares Short (K)

229

Shares Short Prior Month (K)

212

Stock Financials

EPS

-3.770

EPS Est. Current Year

EPS Est. Next Year

-0.340

EPS Est. Next Quarter

-0.960

Forward EPS

1.#IO

Book Value (p.s.)

4.450

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-43.5

Return on Equity (ttm)

-77.3

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.347

Qtrly Earnings Growth

Operating Cash Flow (M)

-35.09

Levered Free Cash Flow (M)

-20.94

FoxReading.com

Valuation

P/E

-3.15

P/E Growth Ratio

-0.01

P/BV

2.67

P/S

P/CF

-5.71

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.